Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
81.00    0.00 (0.00%)
Bid:
80.00
Ask:
82.00
Spread: 2.00 (2.50%)
Market Cap: £11.75m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Form 8.5 (EPT/NON-RI)

Today 08:53

RNS Number : 5838K
Cavendish Capital Markets Limited
01 July 2026
 

FORM 8.5 (EPT/NON-RI)

 

 

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Cavendish Capital Markets Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Reabold Resources Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Reabold Resources Plc

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

30/06/2026

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Union Jack Oil Plc

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ORD 100P

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

67,716

 

0.47

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

67,716

 

0.47

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ORD 100P

 

Sales

15

81.977

81.977

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

01/07/2026

Contact name:

David Evans

Telephone number:

+44 (0) 20 7220 0599

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOUPUGAMUPQUMG
Date   Source Headline
7th Dec 20117:00 amRNSDisposal
28th Sep 20117:00 amRNSHalf Yearly Report
19th Sep 20117:00 amRNSOrderly wind down of Adventis Health
30th Jun 20116:15 pmRNSResult of AGM
23rd Jun 20117:00 amRNSNPA Appeal Upheld
6th Jun 201111:14 amRNSPosting of Annual Report and Notice of AGM
27th May 20117:00 amRNSPreliminary Results - year ended 31 December 2010
12th May 20112:54 pmRNSDirectorate Change
10th May 20117:00 amRNSTrading Update
20th Apr 201112:40 pmRNSDirectorate Change
4th Apr 20119:56 amRNSDirectorate Change
23rd Mar 20112:55 pmRNSNPA - termination of recognition
4th Mar 201111:38 amRNSChange of Registered Office
14th Feb 20117:00 amRNSDirectorate Change
27th Jan 20117:00 amRNSTrading Update
9th Nov 20107:00 amRNSDirectorate Change
15th Sep 20107:00 amRNSDirector Declaration
15th Sep 20107:00 amRNSInterim Results - half year ended 30 June 2010
18th Aug 20107:00 amRNSTrading Update
13th Aug 201012:25 pmRNSDirector/PDMR Shareholding
19th May 20104:01 pmRNSResult of AGM
19th May 20107:00 amRNSAGM Statement
5th May 201010:55 amRNSAnnual Report Published
30th Apr 20107:00 amRNSSettlement of Litigation
29th Apr 20101:30 pmRNSre RNS announcement
29th Apr 20107:00 amRNSSettlement of Litigation
29th Mar 20104:44 pmRNSDirectors' Dealings and Options Exercise
24th Mar 20107:00 amRNSFinal Results
2nd Feb 20107:00 amRNSAcquisition
29th Jan 20107:00 amRNSTrading Statement
16th Dec 200912:05 pmRNSHolding(s) in Company
19th Nov 20094:42 pmRNSHolding(s) in Company
12th Nov 20094:14 pmRNSHolding(s) in Company
12th Nov 20092:43 pmRNSHolding(s) in Company
11th Nov 20097:00 amRNSDirector/PDMR Shareholding
10th Nov 20092:23 pmRNSDirector/PDMR Shareholding
5th Nov 20097:00 amRNSPlacing
30th Sep 20097:00 amRNSInterim results
30th Jul 20097:00 amRNSTrading Update
3rd Jul 20095:35 pmRNSPayments of deferred and earn-out consideration
1st Jul 20094:48 pmRNSGrant of Share Options
3rd Jun 200912:53 pmRNSResult of AGM
3rd Jun 20097:00 amRNSAGM Statement
11th May 20095:04 pmRNSAnnual Report & Notice of AGM
15th Apr 20091:24 pmRNSHolding(s) in Company
15th Apr 200910:10 amRNSFinal Dividend
15th Apr 20097:00 amRNSFinal Results
12th Feb 20093:47 pmRNSDirector/PDMR Shareholding
29th Jan 20097:00 amRNSTrading Statement
21st Jan 20097:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.